Search Results 1321-1330 of 22003 for Inhibition

1. A Phase 3 Randomized, Placebo-controlled, Double-blind Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Subjects with Metastatic Prostate Cancer - Mayo Clinic

   Prior treatment with a PARP inhibitor. Systemic therapy (i.e., novel second-generation AR-targeted therapy such as enzalutamide, apalutamide, or ...

2. (Z)-Endoxifen For The Treatment Of Premenopausal Women With ER+/HER2- Breast Cancer - Mayo Clinic

   Ongoing or active infection requiring systemic treatment with strong inhibitors/inducers of CYP450 enzymes (including bacterial infection, fungal infection, or ...

3. Marijuana and depression: What's the link? - Mayo Clinic

   Selective serotonin reuptake inhibitors (SSRIs) · Serotonin and norepinephrine reuptake inhibitors (SNRIs) · Sleep tips: 6 steps to better sleep · Smokeless ...

4. Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer - Mayo Clinic

   About this study. RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using letrozole may fight breast cancer by lowering the ...

5. Plexiform neurofibroma - Diagnosis and treatment - Mayo Clinic

   Mirdametinib (GOMEKLI), another MEK inhibitor ... Researchers continue to study MEK inhibitors beyond selumetinib as treatments for plexiform neurofibromas.

6. Study of Treg Therapy in Subclinical Inflammation in Kidney Transplantation (TASK) - Mayo Clinic

   Known hypersensitivity to mTOR inhibitors or contraindication to everolimus (including history of wound healing complications). Any chronic illness ...

7. Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer - Mayo Clinic

   Patients must have biopsy-proven cyclin-dependent kinase inhibitor 2A (p16)+ oropharynx cancer; the histologic evidence of invasive squamous cell carcinoma ...

8. A Study to Compare Cabozantinib versus Sunitinib to Treat Metastatic Variant Histology Renal Cell Carcinoma Patients - Mayo Clinic

   ... inhibitors. The patient may have received treatment with immune checkpoint therapy including nivolumab as a single agent or nivolumab plus ipilimumab in ...

9. A Study of Selpercatinib Following Definitive Locoregional Treatment in Participants with Non-small Cell Lung Cancer - Mayo Clinic

   * Prior treatment with a selective RET inhibitor (e.g. selpercatinib or pralsetinib). Note: Other protocol defined Inclusion/Exclusion Criteria may apply ...

10. Temozolomide and Irinotecan Hydrochloride with or without Bevacizumab in Treating Young Patients with Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors - Mayo Clinic

    Patients must not have previously received bevacizumab, irinotecan, temozolomide or other anti-vascular endothelial growth factor (VEGF) inhibitor; Patients ...